Blood Pressure in Patients With Migraine Treated With Monoclonal Anti-CGRP (Receptor) Antibodies: A Prospective Follow-up Study

BACKGROUND AND OBJECTIVES: Anti–calcitonin gene-related peptide (CGRP) (receptor) antibodies are approved as preventive treatment for migraine. Recent concerns have been raised after a retrospective analysis of postmarketing case reports of elevated blood pressure (BP) associated with erenumab. In t...

Descripción completa

Detalles Bibliográficos
Autores principales: de Vries Lentsch, Simone, van der Arend, Britt W.H., Maassen VanDenBrink, Antoinette, Terwindt, Gisela M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620812/
https://www.ncbi.nlm.nih.gov/pubmed/36195452
http://dx.doi.org/10.1212/WNL.0000000000201008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620812/
https://www.ncbi.nlm.nih.gov/pubmed/36195452
http://dx.doi.org/10.1212/WNL.0000000000201008

Ejemplares similares